SAN DIEGO (AP) — SAN DIEGO (AP) — Kura Oncology Inc. (KURA) on Wednesday reported a loss of $68.3 million in its second quarter.

The San Diego-based company said it had a loss of 77 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.

The biopharmaceutical company posted revenue of $20.9 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $16.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KURA at https://www.zacks.com/ap/KURA